568 related articles for article (PubMed ID: 33798845)
21. Design, synthesis, analgesic, anti-inflammatory activity of novel pyrazolones possessing aminosulfonyl pharmacophore as inhibitors of COX-2/5-LOX enzymes: Histopathological and docking studies.
Abdelgawad MA; Labib MB; Ali WAM; Kamel G; Azouz AA; El-Nahass ES
Bioorg Chem; 2018 Aug; 78():103-114. PubMed ID: 29550530
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of anti-inflammatory, analgesic activities, and side effects of some pyrazole derivatives.
Domiati S; El-Mallah A; Ghoneim A; Bekhit A; El Razik HA
Inflammopharmacology; 2016 Aug; 24(4):163-72. PubMed ID: 27342269
[TBL] [Abstract][Full Text] [Related]
23. Novel tetrazole-based selective COX-2 inhibitors: Design, synthesis, anti-inflammatory activity, evaluation of PGE
Labib MB; Fayez AM; El-Nahass ES; Awadallah M; Halim PA
Bioorg Chem; 2020 Nov; 104():104308. PubMed ID: 33011534
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of some new pyrazolyl-pyrazolines as potential anti-inflammatory, analgesic and antibacterial agents.
Viveka S; Dinesha ; Shama P; Nagaraja GK; Ballav S; Kerkar S
Eur J Med Chem; 2015 Aug; 101():442-51. PubMed ID: 26186150
[TBL] [Abstract][Full Text] [Related]
25. Investigation of indole functionalized pyrazoles and oxadiazoles as anti-inflammatory agents: Synthesis, in-vivo, in-vitro and in-silico analysis.
Kumar D; Kumar RR; Pathania S; Singh PK; Kalra S; Kumar B
Bioorg Chem; 2021 Sep; 114():105068. PubMed ID: 34130110
[TBL] [Abstract][Full Text] [Related]
26. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation properties of new 2-(4-isobutylphenyl)propanoic acid derivatives.
Raval JP; Gandhi AN; Akhaja TN; Myangar KN; Patel NH
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):110-6. PubMed ID: 21612370
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis and analgesic/anti-inflammatory evaluation of novel diarylthiazole and diarylimidazole derivatives towards selective COX-1 inhibitors with better gastric profile.
Abdelazeem AH; El-Saadi MT; Safi El-Din AG; Omar HA; El-Moghazy SM
Bioorg Med Chem; 2017 Jan; 25(2):665-676. PubMed ID: 27916468
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biological evaluation of new pyrazolone-pyridazine conjugates as anti-inflammatory and analgesic agents.
Khalil NA; Ahmed EM; Mohamed KO; Nissan YM; Zaitone SA
Bioorg Med Chem; 2014 Apr; 22(7):2080-9. PubMed ID: 24631365
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of novel thiazolidinone derivatives as potential anti-inflammatory agents.
Hu J; Wang Y; Wei X; Wu X; Chen G; Cao G; Shen X; Zhang X; Tang Q; Liang G; Li X
Eur J Med Chem; 2013 Jun; 64():292-301. PubMed ID: 23644212
[TBL] [Abstract][Full Text] [Related]
32. Novel 1,5-diaryl pyrazole-3-carboxamides as selective COX-2/sEH inhibitors with analgesic, anti-inflammatory, and lower cardiotoxicity effects.
Hendawy OM; Gomaa HAM; Alzarea SI; Alshammari MS; Mohamed FAM; Mostafa YA; Abdelazeem AH; Abdelrahman MH; Trembleau L; Youssif BGM
Bioorg Chem; 2021 Nov; 116():105302. PubMed ID: 34464816
[TBL] [Abstract][Full Text] [Related]
33. Molecular docking and synthesis of caffeic acid analogous and its anti-inflammatory, analgesic and ulcerogenic studies.
Al-Ostoot FH; Zabiulla ; Grisha S; Mohammed YHE; Vivek HK; Ara Khanum S
Bioorg Med Chem Lett; 2021 Feb; 33():127743. PubMed ID: 33316405
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of N-benzenesulfonamide-1H-pyrazoles bearing arylsulfonyl moiety: novel celecoxib analogs as potent anti-inflammatory agents.
Abdel-Aziz HA; Al-Rashood KA; ElTahir KE; Suddek GM
Eur J Med Chem; 2014 Jun; 80():416-22. PubMed ID: 24794773
[TBL] [Abstract][Full Text] [Related]
35. Synthesis Under Microwave Irradiation and Molecular Docking of Some Novel Bioactive Thiadiazoles.
Gomha SM; Edress MM; Muhammad ZA; Gaber HM; Amin MM; Matar IK
Mini Rev Med Chem; 2019; 19(5):437-447. PubMed ID: 29595108
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, molecular docking, analgesic, anti-inflammatory, and ulcerogenic evaluation of thiophene-pyrazole candidates as COX, 5-LOX, and TNF-α inhibitors.
Khadri MJN; Ramu R; Simha NA; Khanum SA
Inflammopharmacology; 2024 Feb; 32(1):693-713. PubMed ID: 37985602
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, anti-inflammatory, analgesic, 5-lipoxygenase (5-LOX) inhibition activities, and molecular docking study of 7-substituted coumarin derivatives.
Srivastava P; Vyas VK; Variya B; Patel P; Qureshi G; Ghate M
Bioorg Chem; 2016 Aug; 67():130-8. PubMed ID: 27376460
[TBL] [Abstract][Full Text] [Related]
38. Pyrazole-hydrazone derivatives as anti-inflammatory agents: Design, synthesis, biological evaluation, COX-1,2/5-LOX inhibition and docking study.
Abdelgawad MA; Labib MB; Abdel-Latif M
Bioorg Chem; 2017 Oct; 74():212-220. PubMed ID: 28865292
[TBL] [Abstract][Full Text] [Related]
39. Novel 1,3,4-oxadiazole/oxime hybrids: Synthesis, docking studies and investigation of anti-inflammatory, ulcerogenic liability and analgesic activities.
Abd-Ellah HS; Abdel-Aziz M; Shoman ME; Beshr EA; Kaoud TS; Ahmed AF
Bioorg Chem; 2016 Dec; 69():48-63. PubMed ID: 27669120
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, characterization, evaluation and molecular dynamics studies of 5, 6-diphenyl-1,2,4-triazin-3(2H)-one derivatives bearing 5-substituted 1,3,4-oxadiazole as potential anti-inflammatory and analgesic agents.
Banerjee AG; Das N; Shengule SA; Srivastava RS; Shrivastava SK
Eur J Med Chem; 2015 Aug; 101():81-95. PubMed ID: 26117820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
